DJSN is the National Social Security Council of Indonesia and it is in charge of ensuring that the five programs that compose SJSN, the national healthcare protection determined by law, are well implemented both in terms of effectiveness and sustainability. Each program is covering an area of healthcare such as employees’ protection and accident insurance.
Contact
Address: Kementerian Koordinator Bidang Pembangunan Manusia dan Kebudayaan – Floor 4, Jalan Medan Merdeka Barat No.3, RT.2/RW.3, Gambir, Jakarta Pusat, DKI Jakarta, 10110, Indonesia Jakarta, Indonesia
Tel. 021.385.2165
Website: http://djsn.go.id/
The biggest pharma stories from Southeast Asia, including GSK’s new HPF manufacturing investment, license suspensions for Samco Farma and Ciubros Farma after Indonesia’s acute kidney injury crisis, Kalbe’s Aventis share…
Takeda gets a first approval for QDENGA, its dengue vaccine, which has been given the green light by the Indonesian National Agency for Drug and Food Control, Badan Pengawas Obat…
With a market value of USD 5.2 billion, Kalbe Farma has consolidated into Indonesia’s undisputed national pharma champion and has established a footprint in many ASEAN countries as well as…
The latest from the pharma industry in Southeast Asia, including underwhelming results from Kalbe Pharma, Indonesia’s largest pharma company; Novavax’s vaccine manufacturing plans in the Philippines; the promising future of…
Evie Yulin, biopharma country director at Merck Indonesia, speaks towards the meaning of innovation in emerging countries and how the company engages in innovation beyond products. Since 2012, Merck has been…
Marlia Hayati and Joey Romana, President Director and Vice President Director at PT Darya-Varia Laboratoria, share insights about the company’s strong brand equity and pioneering manufacturing strategy. In 2016, the…
Haris Izmee, director at GE Healthcare Indonesia, explains the strong commitment of the company towards improving access, affordability and quality and highlights the company’s significant investments in internal capabilities and…
Maura Linda Sitanggang, director general at the Indonesian Ministry of Health, discusses the plans being rolled out to ensure that all Indonesians have access to medicines and how the Indonesian…
The Halal Product Assurance Law, enacted in 2014 and due to be implemented across Indonesia in 2019, will mandate that all food and drink that that enters, is distributed, and…
Milan Paleja, country president and general manager of Novartis Indonesia, discusses his main priorities since assuming his current position and the organization’s business expansion strategy, based on enhancing patient access…
Aylie Widjaja, managing director at Exeltis Indonesia, shares her excitement about developing the company’s footprint in Indonesia, making it a manufacturing hub for Asia, and highlights the challenges in navigating…
Patrick Kalona, Director at Phytochemindo Reksa draws a detailed picture of the traditional and herbal medicine industry in Indonesia in addition to presenting the internationalization and growth strategy for the…
See our Cookie Privacy Policy Here
